1 Bhinder S Majithia V Harisdangkul V . Myasthenia gravis and systemic lupus erythematosus: truly associated or coincidental—two case reports and review of the literature. Clin Rheumatol2006; 25: 55–56.
2.
2 Park MJ Kim YA Lee SS Kim BC Kim MK Cho KH . Appearance of systemic lupus erythematosus in patients with myasthenia gravis following thymectomy: two case reports. J Korean Med Sci2004; 19: 134–136.
3.
3 Barbosa RE Córdova S Cajigas JC . Coexistence of systemic lupus erythematosus and myasthenia gravis. Lupus2000; 9: 156–157.
4.
4 Mevorach D Perrot S Buchanan NM . Appearance of systemic lupus erythematosus after thymectomy: four case reports and review of the literature. Lupus1995; 4: 33–37.
5.
5 Sthoeger Z Neiman A Elbirt D . High prevalence of systemic lupus erythematosus in 78 myasthenia gravis patients: a clinical and serologic study. Am J Med Sci2006; 331: 4–9.
6.
6 Gerli R Paganelli R Cossarizza A . Long-term immunologic effects of thymectomy in patients with myasthenia gravis. J Allergy Clin Immunol1999; 103: 865–872.
7.
7 Calabrese LH Bach JF Currie T Vidt D Clough J Krakauer RS . Development of systemic lupus erythematosus after thymectomy for myasthenia gravis. Studies of suppressor cell function. Arch Intern Med1981; 141: 253–255.
8.
8 Smith HR Green DR Smathers PA Gershon RK Raveche ES Steinberg AD . Induction of autoimmunity in normal mice by thymectomy and administration of polyclonal B cell activators: association with contrasuppressor function. Clin Exp Immunol1983; 51: 579–586.
9.
9 Le Loet X Pouyol F Lees O Ducastelle T Godin M Deshayes P . Acute systemic lupus erythematosus after thymectomy for myasthenia. Sequential study of lymphocyte subpopulations. Rev Med Interne1986; 7: 425–432.
10.
10 Conti-Fine BM Milani M Kaminski HJ . Myasthenia gravis: past, present, and future. J Clin Invest2006; 116: 2843–2854.
11.
11 Meraouna A Cizeron-Clairac G Panse RL . The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood2006; 108: 432–440.
12.
12 Ishikawa S Sato T Abe M . Aberrant high expression of Blymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J Exp Med2001; 193: 1393–1402.
13.
13 Ishikawa S Nagai S Sato T . Increased circulating CD11b+CD11c+ dendritic cells (DC) in aged BWF1 mice which can be matured by TNF-α into BLC/CXCL13-producing DC. Eur J Immunol2002; 32: 1881–1887.
14.
14 Ito T Ishikawa S Sato T . Defective B1 cell homing to the peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for systemic lupus erythematosus. J Immunol2004; 172: 3628–3634.
15.
15 Sato T Ishikawa S Akadegawa K . Aberrant B1 cell migration into the thymus results in activation of CD4 T cells through its potent antigen-presenting activity in the development of murine lupus. Eur J Immunol2004; 34: 3346–3358.
16.
16 Ishikawa S Matsushima K . Aberrant B1 cell trafficking in a murine model for lupus. Front Biosci2007; 12: 1790–1803.
